Supporting your work with life science and clinical testing products

Supporting your work with life science and clinical testing products

ALEX2 Allergy Explorer Kit

Quantitative/semi-quantitative test for the measurement of allergen specific IgE (slgE) or total IgE (tlgE) in a variety of sample types.

GeneProof CMV PCR Kit

Cytomegalovirus PCR kit provides precise, fully traceable quantification according to 1st WHO International Standard NIBSC 09/162.

Pancreatic Elastase Chemiluminescence ELISA

A chemiluminescent immunoassay for the quantitative determination of pancreatic elastase in human stool. For In Vitro Diagnostic use in U.S.

AutoPlex™ GI Biomarker Panels

Test for multiple GI symptom markers in one multiplex GI panel, using a single stool extract. Compatible with our universal stool extraction device.
Scientific Solutions

Scientific Solutions for Life

As a global leader in immunodiagnostics and molecular diagnostics, we support you with proprietary walk-away, sample-to-answer solutions in the areas of gastroenterology, specialty allergy, infectious disease, immunology, diabetes & obesity, and endocrinology. Our comprehensive product line includes life science instruments, life science assays, clinical diagnostic instruments, clinical diagnostic assays, and reagents.

MORE ABOUT ALPCO

News & Events

Keep up with the latest ALPCO news, products, and solutions, and join us at upcoming trade shows and conferences.

VIEW ALL NEWS & EVENTS
Meet ALPCO at MEDICA 2022, November 14-17 in Düsseldorf, Germany
Explore what we have to offer at the conference focused on medical technology, health IT, laboratory techniques, and digital innovations.
LEARN MORE
Meet ALPCO at AACC 2023, July 23-27 in Anaheim, CA
Join ALPCO as we exchange information and ideas with the global laboratory medicine community and share our cutting-edge platforms and products.
LEARN MORE

News & Events

Keep up with the latest ALPCO news, products, and solutions, and join us at upcoming trade shows and conferences.

Recent posts

An End to Subjective RPR Reading?
An End to Subjective RPR Reading? Development of a Novel Automated Nontreponemal Immunoassay for Syphilis
Discover ALPCO’s novel automated nontreponemal immunoassay for syphilis testing. Reduce subjectivity, improve workflow efficiency, and support faster treatment decisions.
View Now
Variation In Calprotectin Results by Methodology
Same Sample, Different Result? What New Research Reveals About Fecal Calprotectin Variability
In a head-to-head comparison of FDA-cleared assays and a novel ALPCO method, investigators observed wide variability in specificity and false-positive rates across platforms, raising important questions about standardization and clinical interpretation.
View Now

Resources

Our full library of resources includes documents, webinars and videos that can make your research or diagnostics more productive and insightful.

VIEW ALL RESOURCES
The Relationship Between Glucagon and Energy Homeostasis
Glucagon is a gut hormone generated as a result of post translational modifications during proglucagon processing in the pancreas1,2,3. Research has demonstrated that glucagon...
LEARN MORE
ALPCO Announces Summer 2019 Diabetes Research Travel Grant Recipient
Salem, NH, September 23, 2019 FOR IMMEDIATE RELEASE - Today ALPCO announced that the latest recipient of its Young Investigator Award: The Diabetes Research Travel Grant...
LEARN MORE

Resources

Our full library of resources includes documents, webinars, and videos that can make your research or diagnostics more productive and insightful.

Recent posts

An End to Subjective RPR Reading?
An End to Subjective RPR Reading? Development of a Novel Automated Nontreponemal Immunoassay for Syphilis
Discover ALPCO’s novel automated nontreponemal immunoassay for syphilis testing. Reduce subjectivity, improve workflow efficiency, and support faster treatment decisions.
View Now
Variation In Calprotectin Results by Methodology
Same Sample, Different Result? What New Research Reveals About Fecal Calprotectin Variability
In a head-to-head comparison of FDA-cleared assays and a novel ALPCO method, investigators observed wide variability in specificity and false-positive rates across platforms, raising important questions about standardization and clinical interpretation.
View Now